Literature DB >> 34415785

Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.

Young Sub Lee1, Moon Hyung Choi2, Young Joon Lee2, Dongyeob Han3, Dong-Hyun Kim4.   

Abstract

OBJECTIVES: To assess the apparent diffusion coefficient (ADC) values and the T1 and T2 values derived from nonenhanced (NE) and contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) in the prostate gland and to evaluate differences in values among prostate cancer, the normal peripheral zone (PZ) and the normal transition zone (TZ).
METHODS: Fifty-seven patients (median age, 73 years; range, 48-86) with prostate cancer who underwent multiparametric MRI including NE and CE MRF were included in this study. T1 and T2 values were extracted from NE and CE MRF, respectively. Five quantitative values (the ADC, NE T1, NE T2, CE T1 and CE T2 values) were measured in three areas: prostate cancer, PZ and TZ. We compared the values among the three areas and evaluated the differences between NE MRF and CE MRF values.
RESULTS: ADC values and MRF-derived values were significantly higher in PZ than prostate cancer or TZ (p < 0.001). TZ had a significantly lower CE T1 but significantly higher values of the other variables than prostate cancer (p < 0.001). The T1 values in all three areas and the T2 values in prostate cancer and TZ were significantly lower on CE MRF than on NE MRF (p < 0.001).
CONCLUSIONS: Quantitative analysis of NE and CE MRI can be conducted by using the MRF technique. The ADC value and the T1 and T2 values from CE MRF and NE MRF were found to be significantly different between prostate cancer and normal prostate tissue. ADVANCES IN KNOWLEDGE: The T1 and T2 values from contrast-enhanced MR fingerprinting are significantly different between prostate cancer and normal prostate tissue.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34415785      PMCID: PMC8978224          DOI: 10.1259/bjr.20210479

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  29 in total

1.  T2 Mapping in Prostate Cancer.

Authors:  Julia Mai; Mohamed Abubrig; Thomas Lehmann; Tom Hilbert; Elisabeth Weiland; Marc O Grimm; Ulf Teichgräber; Tobias Franiel
Journal:  Invest Radiol       Date:  2019-03       Impact factor: 6.016

2.  Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer.

Authors:  Xianfeng Wang; Thomas Hielscher; Jan Philipp Radtke; Magdalena Görtz; Viktoria Schütz; Tristan Anselm Kuder; Regula Gnirs; Constantin Schwab; Albrecht Stenzinger; Markus Hohenfellner; Heinz-Peter Schlemmer; David Bonekamp
Journal:  Eur J Radiol       Date:  2021-01-13       Impact factor: 3.528

3.  Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics.

Authors:  Aritrick Chatterjee; Geoffrey Watson; Esther Myint; Paul Sved; Mark McEntee; Roger Bourne
Journal:  Radiology       Date:  2015-06-23       Impact factor: 11.105

4.  Quantitative T2-mapping using MRI for detection of prostate malignancy: a systematic review of the literature.

Authors:  Chau Hung Lee
Journal:  Acta Radiol       Date:  2019-01-08       Impact factor: 1.990

5.  Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.

Authors:  Alice C Yu; Chaitra Badve; Lee E Ponsky; Shivani Pahwa; Sara Dastmalchian; Matthew Rogers; Yun Jiang; Seunghee Margevicius; Mark Schluchter; William Tabayoyong; Robert Abouassaly; Debra McGivney; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-02-10       Impact factor: 11.105

6.  Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.

Authors:  Yadong Cui; Siyuan Han; Ming Liu; Pu-Yeh Wu; Wei Zhang; Jintao Zhang; Chunmei Li; Min Chen
Journal:  J Magn Reson Imaging       Date:  2020-02-06       Impact factor: 4.813

Review 7.  The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: a systematic review and meta-analysis.

Authors:  Hiram Shaish; Stella K Kang; Andrew B Rosenkrantz
Journal:  Abdom Radiol (NY)       Date:  2017-01

8.  Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.

Authors:  Francesco Giganti; Giulio Gambarota; Caroline M Moore; Nicola L Robertson; Neil McCartan; Charles Jameson; Simon R J Bott; Mathias Winkler; Brandon Whitcher; Ramiro Castro-Santamaria; Mark Emberton; Clare Allen; Alex Kirkham
Journal:  J Magn Reson Imaging       Date:  2017-11-14       Impact factor: 4.813

9.  MR Fingerprinting for Rapid Quantitative Abdominal Imaging.

Authors:  Yong Chen; Yun Jiang; Shivani Pahwa; Dan Ma; Lan Lu; Michael D Twieg; Katherine L Wright; Nicole Seiberlich; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2016-01-21       Impact factor: 11.105

10.  Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.

Authors:  Sungmin Woo; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  AJR Am J Roentgenol       Date:  2016-04-14       Impact factor: 3.959

View more
  1 in total

1.  Innovations in prostate cancer: introductory editorial.

Authors:  Jurgen J Fütterer; Chan Kyo Kim; Daniel J Margolis
Journal:  Br J Radiol       Date:  2022-03       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.